Lane Generational’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$369K Hold
1,742
0.32% 42
2026
Q1
$341K Hold
1,742
0.27% 39
2025
Q4
$302K Hold
1,742
0.27% 34
2025
Q3
$332K Hold
1,742
0.28% 31
2025
Q2
$313K Hold
1,742
0.29% 32
2025
Q1
$295K Hold
1,742
0.33% 31
2024
Q4
$263K Hold
1,742
0.26% 31
2024
Q3
$270K Hold
1,742
0.34% 30
2024
Q2
$238K Hold
1,742
0.28% 31
2024
Q1
$232K Hold
1,742
0.27% 30
2023
Q4
$240K Hold
1,742
0.3% 29
2023
Q3
$212K Hold
1,742
0.26% 32
2023
Q2
$245K Sell
1,742
-48
-3% -$6.62K 0.35% 30
2023
Q1
$253K Hold
1,790
0.32% 29
2022
Q4
$280K Hold
1,790
0.4% 30
2022
Q3
$220K Sell
1,790
-388
-18% -$51.1K 0.31% 31
2022
Q2
$290K Hold
2,178
0.39% 30
2022
Q1
$298K Hold
2,178
0.27% 33
2021
Q4
$377K Buy
+2,178
New +$331K 0.32% 29

Other funds holding DGX

Lane Generational's DGX Position: Q2 2026 in Review

Lane Generational held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,742 shares worth $369K. The position accounts for 0.32% of the portfolio, ranked #42.

Lane Generational first reported a position in DGX in Q4 2021 and has held it in 19 quarters since. The position peaked at $377K in Q4 2021. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Lane Generational held 1,742 shares of Quest Diagnostics worth $369K as of Q2 2026.
  • Lane Generational left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.32% of Lane Generational's portfolio in Q2 2026, its #42 holding.
  • Lane Generational first reported a position in Quest Diagnostics in Q4 2021 and has held it in 19 quarters since.
  • Lane Generational's Quest Diagnostics position peaked at $377K in Q4 2021.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Lane Generational's 13F filing for Q2 2026, filed 13 Aug 2026.